SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-014395
Filing Date
2024-05-02
Accepted
2024-05-02 16:41:11
Documents
83
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbyi20240331_10q.htm   iXBRL 10-Q 1138082
2 EXHIBIT 10.1 ex_661883.htm EX-10.1 34037
3 EXHIBIT 31.1 ex_647802.htm EX-31.1 8315
4 EXHIBIT 31.2 ex_647803.htm EX-31.2 8340
5 EXHIBIT 32.1 ex_647804.htm EX-32.1 5087
6 EXHIBIT 32.2 ex_647805.htm EX-32.2 5105
  Complete submission text file 0001437749-24-014395.txt   7143267

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20240331.xsd EX-101.SCH 68780
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20240331_cal.xml EX-101.CAL 60890
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20240331_def.xml EX-101.DEF 429837
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20240331_lab.xml EX-101.LAB 403427
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20240331_pre.xml EX-101.PRE 470209
87 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20240331_10q_htm.xml XML 1161066
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 24909193
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)